Zealand Pharma reports positive Phase 2 ZUPREME-2 topline results for petrelintide in overweight/obesity with type 2 diabetes

Zealand Pharma reported positive Phase 2 ZUPREME-2 topline results for its amylin analog petrelintide in overweight/obesity with type 2 diabetes, though the weight-loss data was soured by blood sugar results, per FierceBiotech.

Detected & updated continuously · Source: Nebula